Literature DB >> 8490476

Acute renal failure during interferon treatment.

I H Fahal1, N Murry, P Chu, G M Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8490476      PMCID： PMC1677459          DOI： 10.1136/bmj.306.6883.973

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Nephrotic syndrome during treatment with interferon.

Authors:  P Selby; J Kohn; J Raymond; I Judson; T McElwain
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

2.  Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.

Authors:  F Mandelli; G Avvisati; S Amadori; M Boccadoro; A Gernone; V M Lauta; F Marmont; M T Petrucci; M Tribalto; M L Vegna
Journal:  N Engl J Med       Date:  1990-05-17       Impact factor: 91.245

Review 3.  Alpha interferon in the treatment of hematologic malignancies.

Authors:  M S Roth; K A Foon
Journal:  Am J Med       Date:  1986-11       Impact factor: 4.965

Review 4.  Clinical toxicity of interferons in cancer patients: a review.

Authors:  J R Quesada; M Talpaz; A Rios; R Kurzrock; J U Gutterman
Journal:  J Clin Oncol       Date:  1986-02       Impact factor: 44.544

5.  Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.

Authors:  M Talpaz; H M Kantarjian; K McCredie; J M Trujillo; M J Keating; J U Gutterman
Journal:  N Engl J Med       Date:  1986-04-24       Impact factor: 91.245
  5 in total
  7 in total

1.  Collapsing focal segmental glomerulosclerosis with recovery of renal function: an uncommon complication of interferon therapy for hepatitis C.

Authors:  D F Stein; A Ahmed; V Sunkhara; W Khalbuss
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Analysis of renal function during telaprevir-based triple therapy for chronic hepatitis C.

Authors:  Motoyuki Kohjima; Miho Kurokawa; Munechika Enjoji; Tsuyoshi Yoshimoto; Tsukasa Nakamura; Tomoko Ohashi; Kunitaka Fukuizumi; Naohiko Harada; Yusuke Murata; Kazuhisa Matsunaga; Masaki Kato; Kazuhiro Kotoh; Makoto Nakamuta
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

Review 3.  Interferon-induced acute renal failure: a case report and literature review.

Authors:  R Horowitz; D Glicklich; L B Sablay; P H Wiernik; S Wadler
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

4.  Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Samih H Nasr; M Barry Stokes; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

5.  Thrombotic microangiopathy associated with use of interferon-beta.

Authors:  Teresa Olea; Raquel Díaz-Mancebo; Maria-Luz Picazo; Jorge Martínez-Ara; Angel Robles; Rafael Selgas
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-06-15

Review 6.  Anti-hepatitis C virus drugs and kidney.

Authors:  Paul Carrier; Marie Essig; Marilyne Debette-Gratien; Denis Sautereau; Annick Rousseau; Pierre Marquet; Jérémie Jacques; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2016-11-18

7.  Interferon Induced Focal Segmental Glomerulosclerosis.

Authors:  Yusuf Kayar; Nuket Bayram Kayar; Nadir Alpay; Jamshid Hamdard; Iskender Ekinci; Sebnem Emegil; Rabia Bag Soydas; Birol Baysal
Journal:  Case Rep Nephrol       Date:  2016-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.